The Foundation will fund Dr. Brais’ second research project for an amount of $80,000 in 2018-2019.
The aims of the project “Integrated Validation Pipeline for Candidate Drugs for ARSACS” are to validate candidate compounds in neurons and to combine genomics and proteomics strategies to pinpoint pathways affected by candidate drugs.